UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Time-resolved infrared spectroscopy of excited states of transition metal species

Coordination chemistry reviews, 1993-05, Vol.125 (1), p.101-114

1993

Volltextzugriff (PDF)

High-performance liquid chromatographic characterization of rhenium bipyridine complexes with phosphorus ligands

Chromatographia, 1996-11, Vol.43 (9-10), p.491-495

1996

Volltextzugriff (PDF)

New synthetic routes to biscarbonylbipyridinerhenium(I) complexes cis,trans-[Re(X2bpy)(CO)2(PR3)(Y)n+ (X2bpy = 4,4'-X2-2,2'-bipyridine) via photochemical ligand substitution reactions, and their photophysical and electrochemical properties

Inorganic chemistry, 2000-06, Vol.39 (13), p.2777-2783

2000

Volltextzugriff (PDF)

Excited-state properties and reactivity of [ReCL(CO) 3 (2,2′-bipy)](2,2′-bipy = 2,2′-bipyridyl) studied by time-resolved infrared spectroscopy

Journal of the Chemical Society. Dalton transactions, 1993 (19), p.2977-2979

1993

Volltextzugriff (PDF)

RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance

Oncogene, 2017-11, Vol.36 (48), p.6680-6690

2017

Volltextzugriff (PDF)

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial

The lancet oncology, 2015-03, Vol.16 (3), p.266-273

2015

Volltextzugriff (PDF)

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

Annals of oncology, 2018-08, Vol.29 (8), p.1843-1852

2018

Volltextzugriff (PDF)

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

The Lancet infectious diseases, 2022-08, Vol.22 (8), p.1131-1141

2022

Volltextzugriff (PDF)

Pharmacologically directed strategies in academic anticancer drug discovery based on the European NCI compounds initiative

British journal of cancer, 2017-07, Vol.117 (2), p.195-202

2017

Volltextzugriff (PDF)

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

Annals of oncology, 2019-12, Vol.30 (12), p.2013-2014

2019

Volltextzugriff (PDF)

Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefits

Supportive care in cancer, 2017, Vol.25 (1), p.237-244

2017

Volltextzugriff (PDF)

EPS1.09 Feasibility of cardiac magnetic resonance imaging in older cystic fibrosis patients

Journal of cystic fibrosis, 2023-06, Vol.22, p.S39-S39

2023

Volltextzugriff (PDF)

Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model

BMJ (Online), 2022-07, Vol.378, p.e070379

2022

Volltextzugriff (PDF)

Inhibition of NF- κB Regulator BCL-3 as a Novel Therapeutic Approach for HER2-Positive Breast Cancer

Annals of oncology, 2013-05, Vol.24, p.iii47

2013

Volltextzugriff (PDF)

937 Inhibitors of Bcl-3 as a Novel Therapeutic Strategy for HER2+ Breast Cancer

European journal of cancer (1990), 2012-07, Vol.48, p.S225-S225

2012

Volltextzugriff (PDF)

A Real-world Analysis of the Treatment of HER2+ Metastatic Breast Cancer (mBC) Beyond First-line HER2-directed Therapies

Clinical oncology (Royal College of Radiologists (Great Britain)), 2019-07, Vol.31 (7), p.e108-e108

2019

Volltextzugriff (PDF)

379 Identification and rational in silico-based targeting of a novel mediator of metastatic breast cancer

European journal of cancer (1990), 2014-11, Vol.50, p.122-122

2014

Volltextzugriff (PDF)

Quinols as Novel Therapeutic Agents. 2. 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and Related Agents as Potent and Selective Antitumor Agents

Journal of medicinal chemistry, 2005-01, Vol.48 (2), p.639-644

2005

Volltextzugriff (PDF)

From Scientific Theory to Classroom Practice

The Neuroscientist (Baltimore, Md.), 2011-08, Vol.17 (4), p.382-388

2011

Volltextzugriff (PDF)

Enhancing decision-making about adjuvant chemotherapy in ER+, HER2- early breast cancer (EBC) following EndoPredict testing

Annals of oncology, 2017-09, Vol.28, p.v58-v58

2017

Volltextzugriff (PDF)

Defining the Older Patient Population (>65 Years) Treated for Metastatic Breast Cancer (mBC) Within the Sussex Cancer Network

Clinical oncology (Royal College of Radiologists (Great Britain)), 2018-06, Vol.30 (6), p.e43-e43

2018

Volltextzugriff (PDF)

PMX464, a thiol‐reactive quinol and putative thioredoxin inhibitor, inhibits NF‐κB‐dependent proinflammatory activation of alveolar epithelial cells

British journal of pharmacology, 2008-11, Vol.155 (5), p.661-672

2008

Volltextzugriff (PDF)

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

Annals of oncology, 2019-12, Vol.30 (12), p.2013

2019

Volltextzugriff (PDF)

Photophysical Behavior of a New CO2 Reduction Catalyst, Re(CO)2(bpy){P(OEt)3}2

Inorganic chemistry, 1994-10, Vol.33 (21), p.4712-4717

1994

Volltextzugriff (PDF)

Importance of molar volumes and related parameters in sweet taste chemoreception

Pure and applied chemistry, 1997-01, Vol.69 (4), p.685-692

1997

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(14)
Chemistry
(12)
Physical Sciences
(12)
Humans
(10)
Female
(6)
Oncology
(6)
Chemistry, Inorganic & Nuclear
(5)
Aged
(4)
Adult
(3)
Biochemistry & Molecular Biology
(3)
Cell Line, Tumor
(3)
Chemistry, Multidisciplinary
(3)
Disease-Free Survival
(3)
Exact Sciences And Technology
(3)
Hematology, Oncology And Palliative Medicine
(3)
Male
(3)
Middle Aged
(3)
Patients
(3)
Animals
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Time-resolved infrared spectroscopy of excited states of transition metal species

High-performance liquid chromatographic characterization of rhenium bipyridine complexes with phosphorus ligands

New synthetic routes to biscarbonylbipyridinerhenium(I) complexes cis,trans-[Re(X2bpy)(CO)2(PR3)(Y)n+ (X2bpy = 4,4'-X2-2,2'-bipyridine) via photochemical ligand substitution reactions, and their photophysical and electrochemical properties

Excited-state properties and reactivity of [ReCL(CO) 3 (2,2′-bipy)](2,2′-bipy = 2,2′-bipyridyl) studied by time-resolved infrared spectroscopy

RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Pharmacologically directed strategies in academic anticancer drug discovery based on the European NCI compounds initiative

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefits

EPS1.09 Feasibility of cardiac magnetic resonance imaging in older cystic fibrosis patients

Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model

Inhibition of NF- κB Regulator BCL-3 as a Novel Therapeutic Approach for HER2-Positive Breast Cancer

937 Inhibitors of Bcl-3 as a Novel Therapeutic Strategy for HER2+ Breast Cancer

A Real-world Analysis of the Treatment of HER2+ Metastatic Breast Cancer (mBC) Beyond First-line HER2-directed Therapies

379 Identification and rational in silico-based targeting of a novel mediator of metastatic breast cancer

Quinols as Novel Therapeutic Agents. 2. 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and Related Agents as Potent and Selective Antitumor Agents

From Scientific Theory to Classroom Practice

Enhancing decision-making about adjuvant chemotherapy in ER+, HER2- early breast cancer (EBC) following EndoPredict testing

Defining the Older Patient Population (>65 Years) Treated for Metastatic Breast Cancer (mBC) Within the Sussex Cancer Network

PMX464, a thiol‐reactive quinol and putative thioredoxin inhibitor, inhibits NF‐κB‐dependent proinflammatory activation of alveolar epithelial cells

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial

Photophysical Behavior of a New CO2 Reduction Catalyst, Re(CO)2(bpy){P(OEt)3}2

Importance of molar volumes and related parameters in sweet taste chemoreception

Suchergebnisse filtern